Skip to main content

Value of PET/CT in the management of liver metastases, part 1.

Publication ,  Journal Article
Sacks, A; Peller, PJ; Surasi, DS; Chatburn, L; Mercier, G; Subramaniam, RM
Published in: AJR Am J Roentgenol
August 2011

OBJECTIVE: Metastasis is the most common (95%) of liver lesions. Early diagnosis and staging are the keys to treatment planning and prognosis. There is a consistent benefit to the use of PET/CT for detecting hepatic, local, and distant metastases from a variety of primary malignancies, which can contribute to staging and ultimately helps to establish the best course of treatment and to determine prognosis. CONCLUSION: For colorectal cancer, FDG PET and FDG PET/CT are particularly effective for identification of additional hepatic and extrahepatic metastases, frequently upstaging the tumor stage and affecting management. In addition, PET/CT is very useful in local ablative and systemic therapy assessment and surveillance for liver metastases.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

AJR Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

August 2011

Volume

197

Issue

2

Start / End Page

W256 / W259

Location

United States

Related Subject Headings

  • Sensitivity and Specificity
  • Radiopharmaceuticals
  • Radionuclide Imaging
  • Radiography
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Staging
  • Liver Neoplasms
  • Humans
  • Fluorodeoxyglucose F18
  • Biomarkers, Tumor
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sacks, A., Peller, P. J., Surasi, D. S., Chatburn, L., Mercier, G., & Subramaniam, R. M. (2011). Value of PET/CT in the management of liver metastases, part 1. AJR Am J Roentgenol, 197(2), W256–W259. https://doi.org/10.2214/AJR.10.6331
Sacks, Ari, Patrick J. Peller, Devaki S. Surasi, Luke Chatburn, Gustavo Mercier, and Rathan M. Subramaniam. “Value of PET/CT in the management of liver metastases, part 1.AJR Am J Roentgenol 197, no. 2 (August 2011): W256–59. https://doi.org/10.2214/AJR.10.6331.
Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of liver metastases, part 1. AJR Am J Roentgenol. 2011 Aug;197(2):W256–9.
Sacks, Ari, et al. “Value of PET/CT in the management of liver metastases, part 1.AJR Am J Roentgenol, vol. 197, no. 2, Aug. 2011, pp. W256–59. Pubmed, doi:10.2214/AJR.10.6331.
Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of liver metastases, part 1. AJR Am J Roentgenol. 2011 Aug;197(2):W256–W259.

Published In

AJR Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

August 2011

Volume

197

Issue

2

Start / End Page

W256 / W259

Location

United States

Related Subject Headings

  • Sensitivity and Specificity
  • Radiopharmaceuticals
  • Radionuclide Imaging
  • Radiography
  • Nuclear Medicine & Medical Imaging
  • Neoplasm Staging
  • Liver Neoplasms
  • Humans
  • Fluorodeoxyglucose F18
  • Biomarkers, Tumor